Can Thailand achieve COVID-19 herd immunity? 2022

Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
Department of Physical Education Faculty of Education Kasetsart University Bangkok Thailand.

The COVID-19 outbreak has had a great impact on the social, economic, and health systems of Thailand. A variety of measures to curb the spread of the disease were implemented since the beginning of the pandemic, including a strict national lockdown protocol. The Thai government aimed to achieve herd immunity through an efficient vaccination programme. Initially, vaccine supply shortage and a lack of vaccine options plagued the health system, but this has since been improved. Continuous monitoring of the situation through research is being carried out to assess the level of immunity among the population whereby the current general recommendation is presently a fourth booster dose for adults. Hurdles towards achieving herd immunity remain. One such issue is the low level of vaccine literacy among those that are unvaccinated or inadequately vaccinated. Another obstacle is the sizeable rate of hesitancy towards getting booster doses. Achieving herd immunity in the Thai population would require multilateral cooperation, improved health promotion to target population groups, such as older adults, and a developed distribution system for those with limited access, such as those in the rural areas.

UI MeSH Term Description Entries

Related Publications

Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
December 2021, Global health research and policy,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
November 2020, Journal of immunoassay & immunochemistry,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
January 2020, European physical journal plus,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
March 2021, American journal of clinical pathology,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
February 2021, The Lancet. Respiratory medicine,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
February 2022, Journal of the Royal Society of Medicine,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
April 2020, European review for medical and pharmacological sciences,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
May 2020, Immunity,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
January 2024, PloS one,
Manatee Jitanan, and Tharisara Chirasatienpon, and Rapeeporn Tiamjan, and Kwanjai Amnatsatsue, and Rachanon Nguanjairak, and Adriana Viola Miranda, and Xu Lin, and Dawa Gyeltshen, and Paolo Miguel Manalang Vicerra, and M B N Kouwenhoven
January 2023, International journal of preventive medicine,
Copied contents to your clipboard!